Carzin Xl 4 mg Prolonged-release, FC tablet.
PDF Leaflet Revision Date: 17 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension and symptoms of benign prostatic hyperplasia (BPH).
Dosage (summary)
Initial dose: 4 mg once daily; may increase to 8 mg based on response.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established; doxazosin transfers into breast milk.
Key Drug Interactions
- PDE-5 inhibitors
- Diuretics
- Beta-blockers
- Calcium-channel blockers
- CYP 3A4 inhibitors
Contraindications
- Hypersensitivity to doxazosin
- Gastrointestinal obstruction
- Pregnancy and lactation
- Orthostatic hypotension
- Severe hepatic impairment
Common side effects
- Dizziness
- Headache
- Hypotension
- Palpitations
- Nausea
Counselling Points
- Take with food
- Avoid sudden position changes
- Report prolonged erections
- Caution with activities requiring alertness
Serious warnings
- Postural hypotension
- Priapism
- Cataract surgery risk
Important Disclaimer
The Carzin Xl 4 mg Prolonged-release, FC tablet. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
